Cargando…

Aptamer-Based Proteomic Platform for Human Immune-Mediated Kidney Diseases

Detalles Bibliográficos
Autor principal:	Nishi, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263405/ https://www.ncbi.nlm.nih.gov/pubmed/35812268 http://dx.doi.org/10.1016/j.ekir.2022.05.010

Ejemplares similares

Stability and reproducibility of proteomic profiles measured with an aptamer-based platform
por: Kim, Claire H., et al.
Publicado: (2018)

Inhaled aptamer therapy: A hopeful therapy for lung disease
por: Martin, M. Elena
Publicado: (2023)

Validation of a Novel Modified Aptamer-Based Array Proteomic Platform in Patients with End-Stage Renal Disease
por: Han, Zhongji, et al.
Publicado: (2018)

Routine immunization: an essential but wobbly platform
por: Steinglass, Robert
Publicado: (2013)

Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods
por: Katz, Daniel H., et al.
Publicado: (2022)

Proteomics Analysis of Cancer Exosomes Using a Novel Modified Aptamer-based Array (SOMAscan(TM)) Platform
por: Webber, Jason, et al.
Publicado: (2014)

Synergistic insights into human health from aptamer- and antibody-based proteomic profiling
por: Pietzner, Maik, et al.
Publicado: (2021)

An instructive attempt on developing aptamer-constructed PROTAC for breast cancer treatment
por: Zhang, Yuzhu, et al.
Publicado: (2022)

Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
por: Gold, Larry, et al.
Publicado: (2010)

Aptamer-based multiplexed proteomic technology for biomarker discovery
por: Gold, Larry, et al.
Publicado: (2010)

DNA damage-induced immune response: Micronuclei provide key platform
por: Gekara, Nelson O.
Publicado: (2017)

A DNA nanocapsule with aptamer-controlled open-closure function for targeted delivery
por: Bentin, Thomas
Publicado: (2012)

Detecting blood clots with aptamers: A potentially lifesaving new tool in medicine
por: Rossi, John J.
Publicado: (2023)

Absence of “Original Antigenic Sin” in Autoimmunity Provides an Unforeseen Platform for Immune Therapy
por: Steinman, Lawrence
Publicado: (1999)

A Transcriptional Blueprint for Human and Murine Diabetic Kidney Disease
por: Bhalla, Vivek, et al.
Publicado: (2013)

Paper-Based Microfluidic Platforms for Understanding the Role of Exosomes in the Pathogenesis of Major Blindness-Threatening Diseases
por: Hsu, Min-Yen, et al.
Publicado: (2018)

Microfluidic flow-injection aptamer-based chemiluminescence platform for sulfadimethoxine detection
por: Wang, Yanwei, et al.
Publicado: (2022)

Male human papillomavirus infection post-kidney transplant: an overlooked disease
por: Genzer, Oksana, et al.
Publicado: (2012)

Proteomic Profiles in Advanced Age-Related Macular Degeneration Using an Aptamer-Based Proteomic Technology
por: Lynch, Anne M., et al.
Publicado: (2019)

Whole proteomes as internal standards in quantitative proteomics
por: Ong, Shao-En
Publicado: (2010)

Aptamers: A New Technological Platform in Cancer Immunotherapy
por: Pastor, Fernando
Publicado: (2016)

Functional Network Profiles in ARSACS Disclosed by Aptamer-Based Proteomic Technology
por: Morani, Federica, et al.
Publicado: (2021)

Identification of serum biomarkers for necrotizing enterocolitis using aptamer-based proteomics
por: Mackay, Stephen, et al.
Publicado: (2023)

Combining independent protein and cellular SELEX with bioinformatic analysis may allow high affinity aptamer hit discovery
por: Ducrot, Coline, et al.
Publicado: (2023)

Serum Protein Signatures Using Aptamer-Based Proteomics for Minimal Change Disease and Membranous Nephropathy
por: Muruve, Daniel A., et al.
Publicado: (2022)

Detecting and Discriminating Shigella sonnei Using an Aptamer-Based Fluorescent Biosensor Platform
por: Song, Myeong-Sub, et al.
Publicado: (2017)

Multiplex Viral Detection Platform Based on a Aptamers-Integrated Microfluidic Channel
por: Saraf, Nileshi, et al.
Publicado: (2019)

A plug-and-play aptamer diagnostic platform based on linear dichroism spectroscopy
por: Little, Haydn A., et al.
Publicado: (2023)

The speciation of the proteome
por: Jungblut, Peter R, et al.
Publicado: (2008)

An important resource and analytic platform for human and mouse cardiovascular-related cis-regulatory elements
por: Xie, Longxiang, et al.
Publicado: (2023)

Platform trials as the way forward in infectious disease’ clinical research: the case of coronavirus disease 2019
por: Pericàs, Juan M., et al.
Publicado: (2023)

Pregnancy in chronic kidney disease
por: Sahay, M.
Publicado: (2015)

The modifiers of chronic kidney disease in autosomal dominant polycystic kidney disease and the role of the endothelin-1
por: Einollahi, Behzad, et al.
Publicado: (2016)

Kidney Dysfunction After Acute Heart Failure: Is Acute Kidney Disease the New Acute Kidney Injury?
por: Kwong, Y. Diana, et al.
Publicado: (2021)

Beyond the Glomerulus—Kidney Tubule Markers and Diabetic Kidney Disease Progression
por: Bullen, Alexander L., et al.
Publicado: (2021)

From case studies to community knowledge base: MSeqDR provides a platform for the curation and genomic analysis of mitochondrial diseases
por: Falk, Marni J., et al.
Publicado: (2016)

Delta.AR: An augmented reality-based visualization platform for 3D genome
por: Tang, Bixia, et al.
Publicado: (2021)

Novel Murine Biomarkers of Radiation Exposure Using An Aptamer-Based Proteomic Technology
por: Sproull, Mary, et al.
Publicado: (2021)

Probing the Limits of Aptamer Affinity with a Microfluidic SELEX Platform
por: Ahmad, Kareem M., et al.
Publicado: (2011)

Microarrays as Model Biosensor Platforms to Investigate the Structure and Affinity of Aptamers
por: Martin, Jennifer A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vgkerhq2v9frjtlfjvii927mid